Program GoalsClick here to register for this event
The purpose of this educational activity is to examine the status and application of evidence-based individualized patient therapy utilizing companion diagnostics. Oncology-specific challenges will be discussed relative to practical use of companion diagnostics to guide targeted pharmacologic therapy.
The target audience will be specialists in Internal Medicine including but not limited to those with sub-specialties in Medical Oncology.
Upon completion of this activity participants should be able to:
1. Summarize the progress in pharmacogenomics, with emphasis on use in oncology.
2. Describe the specific challenges in oncology for developing pharmacogenomic markers and companion dx tests.
3. Discuss the range of companion diagnostic tests currently available to the molecular pathologist.
4. Identify cancers where evidence-based companion diagnostics are utilized by the clinician to guide the use of targeted oncologic therapies.
Educational Activity Agenda
- 105 minutes: Course Instructive Materials and Faculty Discussion
Release and Expiration Dates
CME ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED
Enduring Archive CME Release Date: December 15, 2012
As a sponsor accredited by the ACCME, the EOCME requires anyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past twelve months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
The EOCME encourages speakers and authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content or during the presentation.
Planners and Managers
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Physician Accreditation Statement - CME
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Dane Garvin Ltd. (DGL). EOCME is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation - CME
The EOCME designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Elsevier Office of Continuing Medical Education
For information about the physician accreditation of this activity, please contact us at email@example.com.
How to Obtain CME Credit
Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credits™. To receive credit, the course must be completed between December 15, 2012 and December 15, 2013 now expired.
Participation in this activity should be completed in approximately 2.0 hours. Please follow these steps in order to receive CME credit for viewing the webcast:
After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME certificate for participation in this activity.
Should you have any CME questions regarding this activity, please contact:
Lab Professional Credit Designation - P.A.C.E.®
The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 2.0 contact hours of credit.
How to Obtain P.A.C.E.® Credit
Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 2.0 contact hours of P.A.C.E.® approved continuing education. To receive credit, the course must be completed between December 15, 2012 and December 15, 2014.
Participation in this activity should be completed in approximately 2.0 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the enduring material:
Should you have any P.A.C.E.® questions regarding this activity, please contact:
P.A.C.E.® Release and Expiration Dates
Enduring Archive PACE Release Date: December 15, 2012
There is no fee for this educational activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents and/or laboratory tests that are not approved or cleared by the FDA. The Elsevier Office of Continuing Medical Education (EOCME) does not recommend the use of any agents and/or laboratory tests outside of labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Policy on Privacy and Confidentiality
The Elsevier Office of Continuing Medical Education (EOCME) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. EOCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
EOCME and Dane Garvin Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
This program has been made available online.
Copyright© 2012 Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation use granted to the Elsevier Office of Continuing Medical Education (EOCME).
All Images and Content Copyright© 2012. The American Journal of Medicine